表皮生長(zhǎng)因子(EGF)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)
ELISA Kit for Epidermal Growth Factor (EGF)
URG; Beta-Urogastrone; Pro-epidermal growth factor
- 編號(hào)SEA560Hu
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 實(shí)驗(yàn)方法雙抗夾心
- 反應(yīng)時(shí)長(zhǎng)3h
- 檢測(cè)范圍3.9-250pg/mL
- 靈敏度最小可檢測(cè)劑量小于等于1.5pg/mL.
- 樣本類型Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載 英文說(shuō)明書 中文說(shuō)明書
- 規(guī)格 48T96T 96T*5 96T*10 96T*100
- 價(jià)格 ¥ 2092 ¥ 2988 ¥ 13446 ¥ 25398 ¥ 209160
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
實(shí)驗(yàn)結(jié)果圖
-
標(biāo)準(zhǔn)曲線圖
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
本試劑盒用于檢測(cè)表皮生長(zhǎng)因子(EGF)，經(jīng)檢測(cè)與其它相似物質(zhì)無(wú)明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來(lái)源的限制，不可能完成對(duì)所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測(cè)，因此本試劑盒有可能與未經(jīng)檢測(cè)的其它物質(zhì)有交叉反應(yīng)。
回收率
分別于定值血清及血漿樣本中加入一定量的表皮生長(zhǎng)因子(EGF)（加標(biāo)樣品），重復(fù)測(cè)定并計(jì)算其均值，回收率為測(cè)定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) |
| serum(n=5) | 79-97 | 91 |
| EDTA plasma(n=5) | 91-101 | 96 |
| heparin plasma(n=5) | 83-96 | 90 |
精密度
精密度用樣品測(cè)定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差：取同批次試劑盒對(duì)低、中、高值定值樣本進(jìn)行定量檢測(cè),每份樣本連續(xù)測(cè)定20 次，分別計(jì)算不同濃度樣本的平均值及SD值。
批間差：選取3個(gè)不同批次的試劑盒分別對(duì)低、中、高值定值樣本進(jìn)行定量測(cè)定，每個(gè)樣本使用同一試劑盒重復(fù)測(cè)定8次，分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差： CV<10%
批間差： CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的表皮生長(zhǎng)因子(EGF)，并倍比稀釋成1:2，1:4，1:8，1:16的待測(cè)樣本，線性范圍即為稀釋后樣本中表皮生長(zhǎng)因子(EGF)含量的測(cè)定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 80-92% | 80-94% | 80-101% | 82-101% |
| EDTA plasma(n=5) | 90-97% | 79-103% | 90-101% | 79-90% |
| heparin plasma(n=5) | 82-102% | 83-90% | 96-104% | 85-97% |
穩(wěn)定性
經(jīng)測(cè)定，試劑盒在有效期內(nèi)按推薦溫度保存，其活性降低率小于5%。
為減小外部因素對(duì)試劑盒破壞前后檢測(cè)值的影響，實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致，尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來(lái)進(jìn)行操作可減少人為誤差。
實(shí)驗(yàn)流程
1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備；
2. 加樣（標(biāo)準(zhǔn)品及樣本）100µL，37°C孵育1小時(shí)；
3. 吸棄，加檢測(cè)溶液A100µL，37°C孵育1小時(shí)；
4. 洗板3次；
5. 加檢測(cè)溶液B100µL，37°C孵育30分鐘；
6. 洗板5次；
7. 加TMB底物90µL，37°C孵育10-20分鐘；
8. 加終止液50µL，立即450nm讀數(shù)。
實(shí)驗(yàn)原理
將表皮生長(zhǎng)因子(EGF)抗體包被于96孔微孔板中，制成固相載體，向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本，其中的表皮生長(zhǎng)因子(EGF)與連接于固相載體上的抗體結(jié)合，然后加入生物素化的表皮生長(zhǎng)因子(EGF)抗體，將未結(jié)合的生物素化抗體洗凈后，加入HRP標(biāo)記的親和素，再次徹底洗滌后加入TMB底物顯色。TMB在過(guò)氧化物酶的催化下轉(zhuǎn)化成藍(lán)色，并在酸的作用下轉(zhuǎn)化成最終的黃色。顏色的深淺和樣品中的表皮生長(zhǎng)因子(EGF)呈正相關(guān)。用酶標(biāo)儀在450nm波長(zhǎng)下測(cè)定吸光度(O.D.值)，計(jì)算樣品濃度。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| APA560Hu02 | 表皮生長(zhǎng)因子(EGF)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA560Hu06 | 表皮生長(zhǎng)因子(EGF)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA560Hu03 | 表皮生長(zhǎng)因子(EGF)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA560Hu04 | 表皮生長(zhǎng)因子(EGF)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA560Hu08 | 表皮生長(zhǎng)因子(EGF)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA560Hu09 | 表皮生長(zhǎng)因子(EGF)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA560Hu02 | 表皮生長(zhǎng)因子(EGF)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA560Hu06 | 表皮生長(zhǎng)因子(EGF)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA560Hu01 | 表皮生長(zhǎng)因子(EGF)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA560Hu01 | 表皮生長(zhǎng)因子(EGF)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAA560Hu05 | 表皮生長(zhǎng)因子(EGF)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA560Hu01 | 表皮生長(zhǎng)因子(EGF)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA560Hu02 | 表皮生長(zhǎng)因子(EGF)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA560Hu71 | 表皮生長(zhǎng)因子(EGF)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAA560Hu22 | 表皮生長(zhǎng)因子(EGF)單克隆抗體 | WB; IHC |
| MAA560Hu24 | 表皮生長(zhǎng)因子(EGF)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA560Hu23 | 表皮生長(zhǎng)因子(EGF)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA560Hu25 | 表皮生長(zhǎng)因子(EGF)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA560Hu27 | 表皮生長(zhǎng)因子(EGF)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA560Hu21 | 表皮生長(zhǎng)因子(EGF)單克隆抗體 | WB; IHC; ICC; IP. |
| HEA560Hu | 表皮生長(zhǎng)因子(EGF)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEA560Hu | 表皮生長(zhǎng)因子(EGF)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| WEA560Hu | 表皮生長(zhǎng)因子(EGF)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA560Hu | 表皮生長(zhǎng)因子(EGF)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA560Hu | 表皮生長(zhǎng)因子(EGF)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| PSA560Hu01 | 表皮生長(zhǎng)因子(EGF)抗體對(duì) | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSA560Hu01 | 表皮生長(zhǎng)因子(EGF)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Journal of Pediatric Surgery | The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model [PubMed: 20438940] |
| Biomark Insights | Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism [PubMed: PMC3623607] |
| Plos one | The Probiotic Mixture VSL#3 Accelerates Gastric Ulcer Healing by Stimulating Vascular Endothelial Growth Factor [PubMed: PMC3590171] |
| Diabetes. | Allogeneic transplantation of an adipose-derived stem cell (ASC) sheet combined with artificial skin accelerates wound healing in a rat wound model of type 2 diabetes and obesity [Pubmed:25795216] |
| Eur Rev Med Pharmacol Sci.? | Association of colon adenomas and skin tags: coincidence or coexistence? [Pubmed:24763889] |
| Int J Clin Exp Med. | The effects of self-assembling peptide RADA16 hydrogel on malignant phenotype of human hepatocellular carcinoma cell [PubMed: 26628972] |
| ACS Applied Materials & Interfaces | Polydopamine nanoparticles modulating stimuli-responsive PNIPAM hydrogels with cell/tissue adhesiveness. [pubmed:27709887] |
| Canadian Journal of Physiology and Pharmacology | The effect of midkine on growth factors and oxidative status in an experimental wound model in diabetic and healthy rats [pubmed:28177680] |
| Journal of Controlled Release | A DPP-IV-resistant glucagon-like peptide-2 dimer with enhanced activity against radiation-induced intestinal injury [pubmed:28522195] |
| Scientific Reports | Optimization of Storage Temperature for Retention of Undifferentiated Cell Character of Cultured Human Epidermal Cell Sheets [pubmed:28811665] |
| International Journal of?Nanomedicine | Micro-/nano-topography of selective laser melting titanium enhances adhesion and proliferation and regulates adhesion-related gene expressions of human?… [Pubmed: 30233172] |
| Neoplasia | Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine [Pubmed: 33212364] |
| Aesthet Surg J | Adipose-Derived Stem Cells Improve the Aging Skin of Nude Mice by Promoting Angiogenesis and Reducing Local Tissue Water [33428732] |
| Cell Death & Disease | Sodium/glucose cotransporter 1-dependent metabolic alterations induce tamoxifen resistance in breast cancer by promoting macrophage M2 polarization [34006822] |
| Stem Cells International | The Paracrine Effect of Adipose-Derived Stem Cells Orchestrates Competition between Different Damaged Dermal Fibroblasts to Repair UVB-Induced Skin??- [33381190] |
| Molecular Biology Reports | Umbilical cord-derived mesenchymal stem cell conditioned medium reverses neuronal oxidative injury by inhibition of TRPM2 activation and the JNK signaling?… [Pubmed:35585377] |
| Biomaterials Advances | Human adipose-derived stem cell-loaded small intestinal submucosa as a bioactive wound dressing for the treatment of diabetic wounds in rats [] |
| Authorea | Syringaresinol attenuates kidney injury by inhibition of pyroptosis via activating the Nrf2 antioxidant pathway in diabetic nephropathy [] |
| Biointerface Research in Applied Chemistry | Beetroot Improves the Therapeutic Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells in Preventing Cisplatin Induced Nephrotoxicity in Male Rats [] |
